FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
FDA to pull common but ineffective cold medicine from market
The FDA's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral phenylephrine, citing concerns with the initial data used to support its approval and new data questioning its ...
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants. "It is the FDA's role to ensure that drugs are safe and effective,
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
DAYTON — The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants that have a common ingredient in them. The FDA said there’s evidence that phenylephrine doesn’t work. Brand names like Sudafed, DayQuil and others contain the ingredient, our sister station WSB-TV reported.
FDA moves to pull popular cold and flu medicines from shelves
The FDA is proposing many popular over-the-counter cold and allergy medications be removed from store shelves. The agency says a common ingredient they share, phenylephrine, doesn’t actually relieve nasal congestion.
U.S. FDA proposes ending use of popular decongestant present in cold medicines
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective,
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
FDA considers pulling some cold medicine
FDA considers pulling some cold medicine
Texas Butter Recall Update as FDA Sets Risk Level
Nearly 80,000lbs of butter is being recalled due to potential missing allergy statements on the packaging, in an incident ...
CBC Online 1380 KCIM3h
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...
STAT17h
How a Trump presidency could affect the FDA, the biotech industry, and its stocks
STAT's Readout LOUD podcast discusses how Trump's second term and the MAHA movement could affect FDA regulation, the ...
Newsweek16m
Supplement Recalls: FDA Warns of Products With 'Hidden Drug Ingredient'
They were voluntarily recalled by California-based company VitalityVita.com after they were found to contain sildenafil—the active ingredient in Viagra—and diclofenac—an FDA-approved drug used to ...
NBC News on MSN20h
FDA proposes ending use of decongestant found in many cold, allergy medicines
It comes more than a year after advisors to the FDA unanimously reached the same conclusion. Based on the data, “we are ...
RFK Jr warns he plans on clearing out entire departments of the FDA
Robert F Kennedy Jr, a likely political appointee in Trump’s new government, has already announced his intentions to clear ...
US FDA approves Johnson & Johnson's device for heart condition
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Fortune on MSN21h
RFK Jr. is expected to join Trump’s government after warning the ‘FDA’s war on public health is about to end,’ telling all employees to ‘pack your bags’
Kennedy Jr. has been a vaccine skeptic, sometimes a conspiracy theorist, and he might just be a part of president-elect ...